date/time interval
- July 1, 2020 - April 30, 2023
Comparative Effectiveness Research to Elucidate Glycemic Control Targets and Optimal Drug Choice for Patients with Type 2 Diabetes at High Risk for COVID-19
Grant
Overview
awarded by
administered by
sponsor award ID
- CER-2017C3-9230
Affiliation
contributor
- Banerjee, Samprit Co-Investigator 2020 - 2023
- Mushlin, Alvin I Principal Investigator 2020 - 2023
- Wang, Fei Co-Investigator 2020 - 2023
- Zhang, Yongkang Co-Investigator 2020 - 2023